Jefferies maintains Aehr Test System at Buy, lowers price target to $140 from $175

Jefferies kept Aehr Test System's rating at Buy but reduced its price target from $175 to $140, a 20% decrease. This new target suggests a 172% upside from the stock's Nov 2 close of $51.47, according to the firm.

Original reporting
Published Nov 3, 2026, 8:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Jefferies maintains Aehr Test System at Buy, lowers price target to $140 from $175 — source image
Decision brief

The 30-second read

$AEHRBearishMed
01

Why it matters

Analyst target reductions often trigger short-term selling pressure, especially for micro‑cap stocks.

02

Market read

The target cut is the primary new information, offering a modest trading signal for AEHR.

03

What to watch

Potential upcoming product launches or contract wins not reflected in the target change.

Relevance 6/10Novelty 5/10Timing: post-market

Background

Jefferies maintains a Buy rating but reduces its price target, implying a revised upside estimate.

Company-level read

Ticker impact

$AEHRBearishMedium confidence
Context

Jefferies lowered its price target for Aehr Test System to $140 from $175, indicating a 20% reduction in valuation.

Expected impact

likely downside as investors price in the lower target

Evidence & confidence

Analyst downgrade typically leads to short-term price pressure.

Market effects

May affect sentiment toward semiconductor test equipment sector.

Limited to U.S. markets where AEHR trades.

Low

Counterpoint

Target cut could be an overreaction; the stock may rebound if earnings beat expectations.

Key entities

  • Aehr Test System

    U.S.-listed semiconductor test equipment provider (ticker AEHR).

  • Jefferies

    Equity research analyst firm issuing the rating and target.

Related articles

$AEHRHighAI 9/10

Aehr Test Systems (AEHR) (Q1 2027) Earnings Call Highlights: Record Revenue, Raised

Aehr Test Systems (AEHR) reported record Q1 2027 revenue of $33M and raised annual guidance to $150M. CEO Gayn Erickson highlighted a potential large burn-in opportunity, estimating $35M-$70M in revenue per million units shipped. The company expects sequential growth in remaining quarters, with Q4 potentially the highest. Management confirmed they are not supply-constrained and can ship more than guided. Silicon carbide revenue was about $10M in fiscal 2026, with expectations for growth in 2027.

$AEHRHighAI 9/10

AEHR Stock Surges After Massive AI-Driven Earnings Beat

Aehr Test Systems (AEHR) stock rose 26.6% after reporting Q1 FY27 revenue of $33M, up 300% year-over-year and 75% quarter-over-quarter. Adjusted EPS was $0.28, beating estimates. The company raised FY27 revenue guidance to $150M, citing strong demand for AI and power semiconductor testing.

$AEHRHighAI 9/10

Aehr Stock Jumps 16% After Bookings Hit $46.7 Million

Aehr Test Systems (AEHR) shares rose 16.38% premarket after its Q1 revenue tripled to $33.0M, beating estimates. The company raised its full-year outlook to $150M, citing strong bookings and backlog growth. CEO Gayn Erickson highlighted a major AI customer opportunity. According to GuruFocus, there are 6 warning signs with AEHR.

$AEHRHighAI 8/10

Why is Aehr Test Systems stock surging today?

Aehr Test Systems (AEHR) stock surged 18.8% in pre-market trading after reporting record Q1 2027 revenue of $33.0M, up 200% YoY, and raising full-year revenue outlook to $150M. Non-GAAP net income was $9.4M, or $0.28 per share, exceeding analyst estimates. The company cited strong demand for AI semiconductor test solutions and a book-to-bill ratio of 1.4.

$AEHRMed

Aehr stock jumps on beat and raise amid AI demand

Aehr Test Systems (AEHR) shares rose 15% after reporting Q1 revenue of $33M, up 200% YoY, and raising its FY2027 outlook to $150M. The company cited strong demand for its semiconductor testing systems used in AI chips. CEO Gayn Erickson noted a conservative approach to the revised target. Bookings were $46.7M with a book-to-bill ratio of 1.4.